ID: ALA4163178

Max Phase: Preclinical

Molecular Formula: C88H114N16O18

Molecular Weight: 1683.97

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  N[C@@H](Cc1ccc(O)cc1)C(=O)N1Cc2ccccc2C[C@@H]1C(=O)NCC(=O)NCC(=O)NCCCCCC(=O)NCCC(=O)N[C@H](CCCCNC(=O)CCNC(=O)CCCCCNC(=O)CCNC(=O)CNC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O

Standard InChI:  InChI=1S/C88H114N16O18/c89-67(48-58-30-34-64(105)35-31-58)86(119)103-47-17-27-72(103)85(118)102-70(50-57-18-4-1-5-19-57)83(116)101-71(51-62-24-16-23-60-20-10-11-25-66(60)62)82(115)98-54-80(113)96-45-39-77(110)91-41-13-2-6-28-74(107)94-44-38-76(109)92-43-15-12-26-69(88(121)122)100-78(111)40-46-95-75(108)29-7-3-14-42-93-79(112)53-97-81(114)55-99-84(117)73-52-61-21-8-9-22-63(61)56-104(73)87(120)68(90)49-59-32-36-65(106)37-33-59/h1,4-5,8-11,16,18-25,30-37,67-73,105-106H,2-3,6-7,12-15,17,26-29,38-56,89-90H2,(H,91,110)(H,92,109)(H,93,112)(H,94,107)(H,95,108)(H,96,113)(H,97,114)(H,98,115)(H,99,117)(H,100,111)(H,101,116)(H,102,118)(H,121,122)/t67-,68-,69+,70-,71+,72-,73+/m0/s1

Standard InChI Key:  CLNBJAPGQALKME-NQWOLCANSA-N

Associated Targets(Human)

Opioid receptors; mu & delta 1530 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Delta opioid receptor 15096 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mu opioid receptor 19785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1683.97Molecular Weight (Monoisotopic): 1682.8497AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Olson KM, Keresztes A, Tashiro JK, Daconta LV, Hruby VJ, Streicher JM..  (2018)  Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice.,  61  (14): [PMID:29939746] [10.1021/acs.jmedchem.8b00403]

Source